Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 2
1967 6
1968 5
1969 4
1970 12
1971 10
1972 11
1973 15
1974 15
1975 12
1976 13
1977 16
1978 17
1979 16
1980 12
1981 10
1982 17
1983 15
1984 18
1985 32
1986 29
1987 16
1988 27
1989 30
1990 28
1991 37
1992 28
1993 31
1994 37
1995 46
1996 43
1997 53
1998 39
1999 42
2000 60
2001 68
2002 75
2003 70
2004 65
2005 80
2006 91
2007 88
2008 88
2009 89
2010 116
2011 135
2012 137
2013 153
2014 174
2015 153
2016 147
2017 177
2018 158
2019 139
2020 119
2021 107
2022 79
2023 56
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

3,049 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 3 Anus Mucositis or Stomatitis by Functional or Symptomatic Classification, CTCAE"
Page 1
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.
Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. Elad S, et al. CA Cancer J Clin. 2022 Jan;72(1):57-77. doi: 10.3322/caac.21704. Epub 2021 Oct 29. CA Cancer J Clin. 2022. PMID: 34714553 Free article. Review.
Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that affects patients' function, quality of life, and ability to tolerate treatment. In certain patients with cancer, OM is associated with increased mortality. Research on the …
Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that affects patients' function, qua …
Oral pathology in inflammatory bowel disease.
Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B. Muhvić-Urek M, et al. World J Gastroenterol. 2016 Jul 7;22(25):5655-67. doi: 10.3748/wjg.v22.i25.5655. World J Gastroenterol. 2016. PMID: 27433081 Free PMC article. Review.
Specific oral manifestations in patients with CD are as follows: indurate mucosal tags, cobblestoning and mucogingivitis, deep linear ulcerations and lip swelling with vertical fissures. The most common non-specific manifestations, such as aphthous stomatitis and an …
Specific oral manifestations in patients with CD are as follows: indurate mucosal tags, cobblestoning and mucogingivitis, deep linear …
Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.
Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Sroussi HY, et al. Cancer Med. 2017 Dec;6(12):2918-2931. doi: 10.1002/cam4.1221. Epub 2017 Oct 25. Cancer Med. 2017. PMID: 29071801 Free PMC article. Review.
The oral morbidities of radiation therapy include but are not limited to an increased susceptibility to dental caries and periodontal disease. They also include profound and often permanent functional and sensory changes involving the oral soft tissue. These changes range …
The oral morbidities of radiation therapy include but are not limited to an increased susceptibility to dental caries and periodontal diseas …
Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis.
Lee CT, Huang YW, Zhu L, Weltman R. Lee CT, et al. J Dent. 2017 Jul;62:1-12. doi: 10.1016/j.jdent.2017.04.011. Epub 2017 May 3. J Dent. 2017. PMID: 28478213 Review.
Since heterogeneity existed in each outcome (I(2)=94.7, 95.7, 95.3, and 99.3 for implant-based and subject-based peri-implantitis and peri-implant mucositis, respectively), the random-effects model based on the DerSimonian and Laird method, which incor …
Since heterogeneity existed in each outcome (I(2)=94.7, 95.7, 95.3, and 99.3 for implant-based and subject-based peri-implanti …
Peri-implant health and disease. A systematic review of current epidemiology.
Derks J, Tomasi C. Derks J, et al. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334. J Clin Periodontol. 2015. PMID: 25495683 Review.
MATERIAL & METHODS: Data were extracted from identified studies. Meta-analyses for prevalence of peri-implant mucositis and peri-implantitis were performed. The effect of function time and disease definition on the prevalence of peri-implantitis was evaluated by …
MATERIAL & METHODS: Data were extracted from identified studies. Meta-analyses for prevalence of peri-implant mucositis and peri- …
Peri-implant Mucositis.
Froum SJ, González de la Torre E, Rosen PS. Froum SJ, et al. Int J Periodontics Restorative Dent. 2019 Mar/Apr;39(2):e46-e57. doi: 10.11607/prd.3976. Int J Periodontics Restorative Dent. 2019. PMID: 30794253 Review.
Peri-implant mucositis has been defined as a reversible inflammatory reaction in the soft tissues around a functioning implant with no bone loss. This paper reviews the prevalence, etiology, risk indicators, prevention, and treatment of mucositis. Relying on …
Peri-implant mucositis has been defined as a reversible inflammatory reaction in the soft tissues around a functioning implant …
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.
Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M. Zimmermann S, et al. JAMA Dermatol. 2017 Jun 1;153(6):514-522. doi: 10.1001/jamadermatol.2016.5668. JAMA Dermatol. 2017. PMID: 28329382 Free PMC article. Review.
Other sources were screened manually. STUDY SELECTION: Initially, 157 randomized and nonrandomized studies on therapies (systemic immunomodulating therapies or supportive care) for SJS/TEN were selected. ...Glucocorticosteroids were associated with a survival benefit for p …
Other sources were screened manually. STUDY SELECTION: Initially, 157 randomized and nonrandomized studies on therapies (systemic imm …
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Soriano A, Soriano M, Espinosa G, Manna R, Emmi G, Cantarini L, Hernández-Rodríguez J. Soriano A, et al. Front Immunol. 2020 Jun 3;11:865. doi: 10.3389/fimmu.2020.00865. eCollection 2020. Front Immunol. 2020. PMID: 32655539 Free PMC article. Review.
Advances in the treatment of autoinflammatory diseases have been favored by the use of new biologic agents and the performance of a notable number of randomized clinical trials exploring the efficacy and safety of these agents. Clinical trials have contribute …
Advances in the treatment of autoinflammatory diseases have been favored by the use of new biologic agents and the performance of a notable …
Prevalence and Mechanisms of Peri-implant Diseases.
Salvi GE, Cosgarea R, Sculean A. Salvi GE, et al. J Dent Res. 2017 Jan;96(1):31-37. doi: 10.1177/0022034516667484. Epub 2016 Oct 1. J Dent Res. 2017. PMID: 27680028 Review.
Despite the proof of principle that experimentally induced mucositis may be reversible, early diagnosis and management of naturally occurring peri-implant mucositis are clinically relevant. ...Although human periodontitis and peri-implantitis lesions share similarit …
Despite the proof of principle that experimentally induced mucositis may be reversible, early diagnosis and management of naturally o …
Chemotherapy and dysphagia: the good, the bad, the ugly.
Dewan K. Dewan K. Curr Opin Otolaryngol Head Neck Surg. 2020 Dec;28(6):385-391. doi: 10.1097/MOO.0000000000000672. Curr Opin Otolaryngol Head Neck Surg. 2020. PMID: 33027141 Review.
The most common dysphagia causing toxicity of chemotherapeutic agents is mucositis/stomatitis. The use of cisplatin is correlated with increased incidence of mucositis. Similarly, the addition of melphalan is also associated with worsening mucositis an …
The most common dysphagia causing toxicity of chemotherapeutic agents is mucositis/stomatitis. The use of cisplatin is correla …
3,049 results